AbbVie Inc.
10-Q · 2025-11-04T00:00:00Z · 0001551152-25-00004963 tables
Cover (1)
Statements (7)
- R2.htmCondensed Consolidated Statements of Earnings (Unaudited)
9952151 - Statement - Condensed Consolidated Statements of Earnings (Unaudited)
- R3.htmCondensed Consolidated Statements of Comprehensive Income (Unaudited)
9952152 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)
- R4.htmCondensed Consolidated Statements of Comprehensive Income (Parenthetical) (Unaudited)
9952153 - Statement - Condensed Consolidated Statements of Comprehensive Income (Parenthetical) (Unaudited)
- R5.htmCondensed Consolidated Balance Sheets
9952154 - Statement - Condensed Consolidated Balance Sheets
- R6.htmCondensed Consolidated Balance Sheets (Parenthetical)
9952155 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
- R7.htmCondensed Consolidated Statements of Equity (Deficit) (Unaudited)
9952156 - Statement - Condensed Consolidated Statements of Equity (Deficit) (Unaudited)
- R8.htmCondensed Consolidated Statements of Cash Flows (Unaudited)
9952157 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes (14)
- R9.htmBasis of Presentation
9952158 - Disclosure - Basis of Presentation
- R10.htmSupplemental Financial Information
9952159 - Disclosure - Supplemental Financial Information
- R11.htmEarnings Per Share
9952160 - Disclosure - Earnings Per Share
- R12.htmLicensing, Acquisitions and Other Arrangements
9952161 - Disclosure - Licensing, Acquisitions and Other Arrangements
- R13.htmCollaborations
9952162 - Disclosure - Collaborations
- R14.htmGoodwill and Intangible Assets
9952163 - Disclosure - Goodwill and Intangible Assets
- R15.htmRestructuring Plans
9952164 - Disclosure - Restructuring Plans
- R16.htmFinancial Instruments and Fair Value Measures
9952165 - Disclosure - Financial Instruments and Fair Value Measures
- R17.htmPost-Employment Benefits
9952166 - Disclosure - Post-Employment Benefits
- R18.htmEquity
9952167 - Disclosure - Equity
- R19.htmIncome Taxes
9952168 - Disclosure - Income Taxes
- R20.htmLegal Proceedings and Contingencies
9952169 - Disclosure - Legal Proceedings and Contingencies
- R21.htmSegment Information
9952170 - Disclosure - Segment Information
- R22.htmInsider Trading Arrangements
995445 - Disclosure - Insider Trading Arrangements
Tables (10)
- R23.htmSupplemental Financial Information (Tables)
9955511 - Disclosure - Supplemental Financial Information (Tables)
- R24.htmEarnings Per Share (Tables)
9955512 - Disclosure - Earnings Per Share (Tables)
- R25.htmLicensing, Acquisitions and Other Arrangements (Tables)
9955513 - Disclosure - Licensing, Acquisitions and Other Arrangements (Tables)
- R26.htmCollaborations (Tables)
9955514 - Disclosure - Collaborations (Tables)
- R27.htmGoodwill and Intangible Assets (Tables)
9955515 - Disclosure - Goodwill and Intangible Assets (Tables)
- R28.htmRestructuring Plans (Tables)
9955516 - Disclosure - Restructuring Plans (Tables)
- R29.htmFinancial Instruments and Fair Value Measures (Tables)
9955517 - Disclosure - Financial Instruments and Fair Value Measures (Tables)
- R30.htmPost-Employment Benefits (Tables)
9955518 - Disclosure - Post-Employment Benefits (Tables)
- R31.htmEquity (Tables)
9955519 - Disclosure - Equity (Tables)
- R32.htmSegment Information (Tables)
9955520 - Disclosure - Segment Information (Tables)
Details (31)
- R33.htmSupplemental Financial Information (Details)
9955522 - Disclosure - Supplemental Financial Information (Details)
- R34.htmEarnings Per Share (Details)
9955523 - Disclosure - Earnings Per Share (Details)
- R35.htmLicensing, Acquisitions, and Other Arrangement- Acquisition of Gilgamesh Pharmaceuticals, Inc. (Details)
9955524 - Disclosure - Licensing, Acquisitions, and Other Arrangement- Acquisition of Gilgamesh Pharmaceuticals, Inc. (Details)
- R36.htmLicensing, Acquisitions, and Other Arrangement- Acquisitions of Nimble Therapeutics, Inc. (Details)
9955525 - Disclosure - Licensing, Acquisitions, and Other Arrangement- Acquisitions of Nimble Therapeutics, Inc. (Details)
- R37.htmLicensing, Acquisitions, and Other Arrangements (Details) - Cerevel Therapeutics
9955526 - Disclosure - Licensing, Acquisitions, and Other Arrangements (Details) - Cerevel Therapeutics
- R38.htmLicensing, Acquisitions, and Other Arrangements (Details) - ImmunoGen
9955527 - Disclosure - Licensing, Acquisitions, and Other Arrangements (Details) - ImmunoGen
- R39.htmLicensing, Acquisitions and Other Arrangements (Details)
9955528 - Disclosure - Licensing, Acquisitions and Other Arrangements (Details)
- R40.htmCollaborations (Details)
9955529 - Disclosure - Collaborations (Details)
- R41.htmGoodwill and Intangible Assets - Goodwill (Details)
9955530 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)
- R42.htmGoodwill and Intangible Assets - Intangible Assets, Net (Details)
9955531 - Disclosure - Goodwill and Intangible Assets - Intangible Assets, Net (Details)
- R43.htmRestructuring Plans (Details)
9955532 - Disclosure - Restructuring Plans (Details)
- R44.htmFinancial Instruments and Fair Value Measures - Financial Instruments (Details)
9955533 - Disclosure - Financial Instruments and Fair Value Measures - Financial Instruments (Details)
- R45.htmFinancial Instruments and Fair Value Measures - Amount Of Gain/(Loss) Recognized For Derivative Instruments (Details)
9955534 - Disclosure - Financial Instruments and Fair Value Measures - Amount Of Gain/(Loss) Recognized For Derivative Instruments (Details)
- R46.htmFinancial Instruments and Fair Value Measures - Fair Value Measures (Details)
9955535 - Disclosure - Financial Instruments and Fair Value Measures - Fair Value Measures (Details)
- R47.htmFinancial Instruments and Fair Value Measures - Significant Level 3 Unobservable Inputs (Details)
9955536 - Disclosure - Financial Instruments and Fair Value Measures - Significant Level 3 Unobservable Inputs (Details)
- R48.htmFinancial Instruments and Fair Value Measures - Transfers of Assets or Liabilities Into or Out of Level 3 of the Fair Value Hierarchy (Details)
9955537 - Disclosure - Financial Instruments and Fair Value Measures - Transfers of Assets or Liabilities Into or Out of Level 3 of the Fair Value Hierarchy (Details)
- R49.htmFinancial Instruments and Fair Value Measures - Bases Used To Measure The Approximate Fair Values Of Financial Instruments (Details)
9955538 - Disclosure - Financial Instruments and Fair Value Measures - Bases Used To Measure The Approximate Fair Values Of Financial Instruments (Details)
- R50.htmFinancial Instruments and Fair Value Measures - Concentrations of Risk (Details)
9955539 - Disclosure - Financial Instruments and Fair Value Measures - Concentrations of Risk (Details)
- R51.htmFinancial Instruments and Fair Value Measures - Debt and Credit Facilities (Details)
9955540 - Disclosure - Financial Instruments and Fair Value Measures - Debt and Credit Facilities (Details)
- R52.htmPost-Employment Benefits (Details)
9955541 - Disclosure - Post-Employment Benefits (Details)
- R53.htmEquity - Stock-Based Compensation (Details)
9955542 - Disclosure - Equity - Stock-Based Compensation (Details)
- R54.htmEquity - Stock Options (Details)
9955543 - Disclosure - Equity - Stock Options (Details)
- R55.htmEquity - RSUs and Performance Shares (Details)
9955544 - Disclosure - Equity - RSUs and Performance Shares (Details)
- R56.htmEquity - Cash Dividends (Details)
9955545 - Disclosure - Equity - Cash Dividends (Details)
- R57.htmEquity - Stock Repurchase Program (Details)
9955546 - Disclosure - Equity - Stock Repurchase Program (Details)
- R58.htmEquity - Accumulated Other Comprehensive Loss (Details)
9955547 - Disclosure - Equity - Accumulated Other Comprehensive Loss (Details)
- R59.htmEquity - Amounts Reclassified Out Of Accumulated Other Comprehensive Loss (Details)
9955548 - Disclosure - Equity - Amounts Reclassified Out Of Accumulated Other Comprehensive Loss (Details)
- R60.htmIncome Taxes (Details)
9955549 - Disclosure - Income Taxes (Details)
- R61.htmLegal Proceedings and Contingencies (Details)
9955550 - Disclosure - Legal Proceedings and Contingencies (Details)
- R62.htmSegment Information - Additional Information (Details)
9955551 - Disclosure - Segment Information - Additional Information (Details)
- R63.htmSegment Information - Disaggregation of Revenue (Details)
9955552 - Disclosure - Segment Information - Disaggregation of Revenue (Details)